Navigation Links
The Reduction of Eye Fatigue Improves Vision in Older Subjects
Date:8/5/2009

BURLINGTON, N.J., Aug. 5 /PRNewswire/ -- Most people over the age of 40 begin to experience Presbyopia which is the increased difficulty to focus on nearby objects. Although this age related phenomena is usually assisted by reading glasses, a current study performed at the Kajita Clinic in Tokyo, Japan and published in March, 2009 has shown significant improvement in the ability to focus on nearby objects in older subjects (mean age of 53.9 +/- 5.1 years) with supplementation of the antioxidant, astaxanthin.

The researchers suggest that the underlying reason for the improved accommodation ability in the test subjects may be due to the positively activated functions of three muscles in the eye; the constrictor pupillae muscle and dilator pupillae muscle working in coordination with the ciliary muscle. Astaxanthin has been shown in other studies to improve muscle endurance and recovery.

Although the basic measure for presbyopia is to wear glasses, the researchers also suggest that astaxanthin supplementation may slow down the progression of presbyopia and improve asthenopia (eye fatigue).

The current study is the tenth human clinical sponsored by Fuji Chemical Industry Co., Ltd. supporting the role of astaxanthin in the reduction of eye fatigue. The studies were performed over the past 7 years at more than 6 different universities and research institutes.

Fuji Chemical is a Japanese pharmaceutical company with a 60+ year history and the maker of AstaReal astaxanthin. Fuji is the world's leading producer of natural astaxanthin for human nutritional use with state of the art facilities in Hawaii, Sweden and Japan.

Some of the other areas of astaxanthin research that Fuji is actively supporting include cardiovascular, diabetes and metabolic syndrome. Fuji Chemical also holds seven patents for astaxanthin in human application as well as numerous pending patents. Fuji's AstaReal brand of astaxanthin is approved for use in nutritional supplementation in the U.S., Europe, and Japan, as well as other markets worldwide.

For more information: contact@fujihealthscience.com

    For additional information, please contact:
    Yasuko Kuroda
    Fuji Health Science, Inc.
    3 Terri Lane, Unit 12
    Burlington, NJ 08016
    contact@fujihealthscience.com
    tel: 609 386 3030  fax: 609 386 3033


'/>"/>
SOURCE Fuji Health Science, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. New Surgical Device Revolutionizes Face Lifts, Abdominoplasty and Breast Reduction Surgery Promising Patients Quicker Recovery Time, Less Pain and Fewer Bruises
2. Lung volume reduction surgery shown to prolong and improve life for some emphysema patients
3. Fat Reduction Market in Europe to Soar Despite Economic Downturn
4. Federal Judge Orders Schwarzenegger Administration to Comply with Order That Blocks State Reduction for IHSS Worker Wages
5. Caraco Pharmaceutical Laboratories, Ltd. Announces an Indefinite Reduction in its Workforce
6. Hospital Bedside Technology Solution Results in 74 Percent Reduction in Heart Failure Readmission Rate
7. Employees Increasingly Accept and Understand Reductions in Health Plan Benefits and Premium-Cost Sharing
8. Studies Show Groundbreaking 22% Reduction in Depression Symptoms in 4 Hours
9. Maricopa Integrated Health System Reports 90 Percent Reduction in Pressure Ulcers
10. Pharmaceutical Companies Seek to Balance Quality Assurance & Cost Reduction
11. AstraZeneca Studies Show Relief of Nighttime Heartburn and Reduction in GERD-Related Sleep Disturbances
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , ... February 23, 2017 , ... ... of Justice jointly issued a letter to withdraw previous guidance issued ... their gender identity. The guidance issued in May 2016 by the Obama Administration ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... with a clinician-based audience, will be participating in Rare Disease Day events, hosted ... D.C. In addition, Rare Disease Report, a website, weekly e-newsletter and quarterly publication, ...
(Date:2/23/2017)... , ... February 23, 2017 , ... Hamlin Dental Group ... that they are sponsoring a raffle. Throughout the month of February, patients who visit ... a gift card for a dinner for two at the Cheesecake Factory. , ...
(Date:2/23/2017)... Los Angeles, California (PRWEB) , ... February 23, ... ... for Global Sports Development will host a diverse symposium on “Doping ... School of Law and Sheppard Mullin Richter & Hampton LLP. The symposium will ...
(Date:2/23/2017)... ... 23, 2017 , ... ERT, a global data and technology ... Research, a leading clinical development service provider, has selected ERT’s Trial Oversight suite ... in part to an array of circumstances including the use of multiple data ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... 2017 Nevro Corp. (NYSE: NVRO), a global medical ... treatment of chronic pain, today reported financial results for the ... 2016 Accomplishment & Highlights: Achieved ... increase of 228% as reported, over the prior year ... of 612% over the prior year International ...
(Date:2/23/2017)... Calif. , Feb. 23, 2017 ... company focused on the development and commercialization of ... pain, announced that it will release fourth quarter ... Thursday, March 2nd, 2017. AcelRx management will host ... Time (1:30 p.m. Pacific Time) on March 2 ...
(Date:2/23/2017)... , Feb 23, 2017 ... Research and Markets has announced the ... Industry Forecast to 2025" report to their offering. ... of around 1.8% over the next decade to reach approximately $12.8 billion ... estimates and forecasts for all the given segments on global as well ...
Breaking Medicine Technology: